Literature DB >> 6974187

Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes.

J P van der Veen, A G Rolink, E Gleichmann.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6974187

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 2.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

3.  Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E).

Authors:  M Kimura; F M van Rappard-van der Veen; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

4.  Editorial: Making Science Fun - A Tribute to Our Colleague and Friend, Prof. Antonius G. Rolink (1953-2017).

Authors:  Hermann Eibel; Thomas Winkler; Rhodri Ceredig
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

5.  Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells.

Authors:  Debora R Sekiguchi; Robert A Eisenberg; Martin Weigert
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

6.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.